Cigna Corporation announced that health care industry leader Dr. David Brailer, M.D., Ph.D. will join the company as Executive Vice President and Chief Health Officer in early September. As Cigna's first Chief Health Officer, Dr. Brailer will focus on bringing together the company's products, technologies, and services in new and innovative ways to drive more value and help people improve their overall health and vitality. Dr. Brailer will report to David M. Cordani, Cigna Chairman and Chief Executive Officer, and will serve on the company's Enterprise Leadership Team.

Dr. Brailer is founder and Chairman of Health Evolution, an organization that convenes health care leaders as they navigate rapidly changing forces in the industry. David is also Vice Chairman of the Duke-Margolis Health Policy Center. Dr. Brailer will continue to be actively involved with both of those organizations as part of his role at Cigna.

Dr. Brailer has been an investor in numerous health technology and services companies through Health Evolution Partners. In 2004, Brailer was appointed by President George W. Bush as a health policy advisor and became the nation's first National Coordinator for Health Information Technology. Prior to that, he was founder and CEO of CareScience, one of the first health data analytics companies in the internet era.

Dr. Brailer has served on the boards of directors of or as an advisor to numerous health care companies, including Walgreens Boots Alliance, VillageMD, Censeo Health, and Prolacta Bioscience. Dr. Brailer holds doctoral degrees in medicine and economics. David earned his M.D. from West Virginia University and his Ph.D. in economics from The Wharton School of the University of Pennsylvania.

He was appointed a Charles A. Dana Fellow and a Robert Wood Johnson Clinical Scholar at the University of Pennsylvania. He taught for a decade at The Wharton School, where he developed its curriculum on health information technology. Dr. Brailer became board certified in internal medicine after internship and residency at the Hospital of the University of Pennsylvania, where he later practiced infectious diseases and HIV medicine.